should i take bpc 157 with tb500 TB 500 vs 157: Comprehensive comparison of healing peptides BPC-157 (10 mg) + TB-500

(2R,6R)-hydroxynorketamine promotes dendrite outgrowth in human inducible pluripotent stem cell-derived neurons through AMPA receptor with timing and exposure compatible with ketamine infusion pharmacokinetics in humans

Clinical Evidence Current clinical evidence for both peptides remains notably limited in comparison to the extensive body of preclinical data

They serve different needs, different populations, and different goals

Dosage Guidelines by Treatment Goal Acute injury recovery: 500750mcg daily for 24 weeks Chronic condition management: 250500mcg daily for 612 weeks Gut health support: 250500mcg daily for 48 weeks General wellness and prevention: 200300mcg daily, 5 days per week Important: Always consult with a healthcare provider before starting BPC-157 therapy